Cannabis Report
Home > Boards > US Listed > Biotechs >

Tocagen Inc. (TOCA)

TOCA RSS Feed
Add TOCA Price Alert      Hide Sticky   Hide Intro
Moderator: gr8db8
Search This Board: 
Last Post: 6/20/2018 12:36:20 PM - Followers: 7 - Board type: Free - Posts Today: 0

Tocagen Inc. 3030 Bunker Hill Street Suite 230 San Diego, CA 92109 United States 858-412-8400 http://www.tocagen.com Tocagen Inc., a clinical-stage cancer-selective gene therapy company, focuses on developing and commercializing product candidates designed to activate a patient's immune system against their cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to deliver therapeutic genes into the DNA of cancer cells. The company's lead product candidate is Toca 511 & Toca FC that is in Phase 2 portion of a randomized, controlled Phase 2/3 clinical trial for patients with recurrent high grade glioma (HGG). It is also developing Toca 511 & Toca FC in a Phase 1b clinical trial for metastatic cancers, including colorectal, pancreatic, breast, lung, melanoma, and renal. In addition, the company is developing other RRVs to deliver genes to cancer cells against validated immunotherapy targets, such as the checkpoint protein PD-L1. Tocagen Inc. was founded in 2007 and is headquartered in San Diego, California.
Cannabis Report
TOCA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TOCA News: Notice of Effectiveness (effect) 05/24/2018 06:02:14 AM
TOCA News: Current Report Filing (8-k) 05/23/2018 04:12:22 PM
TOCA News: Tocagen to Present Preclinical Data on Anti-PD-L1 Product Candidate Toca 521 at the 2018 Annual Meeting of The American Socie... 05/14/2018 08:00:00 AM
TOCA News: Securities Registration Statement (simplified Form) (s-3) 05/11/2018 04:48:30 PM
TOCA News: Quarterly Report (10-q) 05/11/2018 04:36:17 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#18  Sticky Note Toca 5 Trial link: https://clinicaltrials.gov/ct2/show/NCT02414165 gr8db8 01/02/18 10:30:33 PM
#45   Good observations for direct injection: A surgeon injects gr8db8 06/20/18 12:36:20 PM
#44   Bought in yesterday. Sold today's 10 calls to Jumpinjackas 06/15/18 10:22:32 AM
#43   Inpatient investors that will get out on any stockguard 06/14/18 03:03:17 PM
#42   It's not even trying to run up Jumpinjackas 06/14/18 02:43:36 PM
#41   6/11 Corporate Presentation gr8db8 06/14/18 01:58:17 PM
#40   Toca 6: A phase 1b study of Toca gr8db8 06/04/18 10:02:29 PM
#39   Immunotherapy Clinical Trial at Overlook Medical Center Reveals stockguard 06/04/18 02:33:27 PM
#38   Am a little surprised at the stock selling stockguard 05/24/18 03:45:56 PM
#37   Madhu Kumar has a pretty good success rate. gr8db8 05/24/18 03:17:11 PM
#36   A little more than a year after its stockguard 05/17/18 01:25:59 PM
#35   5/16/2018 Tocagen (NASDAQ:TOCA) initiated with Buy rating and $15 stockguard 05/16/18 11:35:26 AM
#34   BiotechGuy, Contributor stockguard 05/06/18 04:07:25 PM
#33   You might like the read in this article stockguard 05/06/18 04:06:12 PM
#32   gr8db8 Thanks for the link. I like the science stockguard 05/03/18 05:49:58 PM
#31   http://markets.money.cnn.com/cgi-bin/upload.dll/file.png?z758f7c0az7ca9e1ec stockguard 04/24/18 02:53:16 PM
#30   Tocagen and Beijing Apollo Venus Biomedical Technology Limited gr8db8 04/19/18 12:23:36 PM
#29   Abstracts: Toca 6 Phase 1 Data and Immune gr8db8 04/18/18 11:58:16 AM
#28   Yes, Ariad was quite the ride! Back then, gr8db8 03/08/18 01:19:53 PM
#27   Hi gr8db8. Yes, I spent a ton of biotech_researcher 03/08/18 12:04:20 PM
#26   Welcome, biotech_researcher. As you can see this is gr8db8 03/08/18 11:32:15 AM
#25   U.S. Biotech/Pharma Sector Daily Observations Letter: March 7, biotech_researcher 03/08/18 09:15:40 AM
#24   Make that, “now in a ph2/ph3 trial”.... biotech_researcher 03/05/18 08:53:45 PM
#23   I’m in ( 2 weeks ago) after a biotech_researcher 03/04/18 07:47:27 PM
#22   March 8 - Q4 and Full Year 2017 gr8db8 03/04/18 05:38:33 PM
#21   AACR Wednesday, February 14 gr8db8 02/05/18 01:56:47 PM
#20   The Toca-511- and 5-FC-treated animals showed slower tumor gr8db8 01/14/18 10:56:17 PM
#19   Promising development - but no CR:: a virus gr8db8 01/05/18 11:16:06 PM
#18   Toca 5 Trial link: https://clinicaltrials.gov/ct2/show/NCT02414165 gr8db8 01/02/18 10:30:33 PM
#17   However, Toca 511 and 5-FC treatment significantly gr8db8 12/31/17 11:52:57 PM
#16   Price variations due to low volumes are adversely intuitiveone 12/31/17 06:57:10 AM
#15   I haven't seen one way or another whether gr8db8 12/28/17 04:55:14 PM
#14   Agree. I think fever is an indication that gr8db8 12/28/17 04:34:32 PM
#13   I m not invested in toca but here Oren1976 12/16/17 02:18:01 PM
#12   Ok so I see there is fever 2 Oren1976 12/16/17 02:05:50 PM
#11   Hello gr8. Did u find fever as a Oren1976 12/16/17 01:33:20 PM
#10   Great videos. Well done on the testimonials: gr8db8 11/17/17 10:58:28 PM
#9   nm gr8db8 11/17/17 10:58:27 PM
#8   Stifel summary gr8db8 11/15/17 07:35:21 PM
#7   The median survival in this trial is nearly gr8db8 11/04/17 09:14:52 PM
#6   TOCA 5 CLINICAL TRIAL gr8db8 11/04/17 09:10:50 PM
#5   Q3 2017 Earnings Release Wednesday, November 8, 2017 gr8db8 11/04/17 04:20:02 PM
#4   Durable responses observed in recurrent high-grade glioma (rHGG) gr8db8 11/04/17 04:14:22 PM
#3   More than a quarter of patients with a gr8db8 11/04/17 04:03:38 PM
#2   Investigators said once inside the cancer cell, the gr8db8 11/04/17 04:00:18 PM
#1   TOCA buy 15.90 stocktrademan 05/24/17 12:28:52 PM
PostSubject